MERKEL CELL CARCINOMA, RECURRENT

Clinical trials for MERKEL CELL CARCINOMA, RECURRENT explained in plain language.

Never miss a new study

Get alerted when new MERKEL CELL CARCINOMA, RECURRENT trials appear

Sign up with your email to follow new studies for MERKEL CELL CARCINOMA, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for Tough-to-Treat neuroendocrine cancers

Disease control Recruiting now

This early-stage study is testing a new drug called BL-M14D1 in 120 patients with advanced small cell lung cancer and other neuroendocrine cancers that have spread and stopped responding to standard treatments. The main goals are to find the safest dose and see how the body proce…

Matched conditions: MERKEL CELL CARCINOMA, RECURRENT

Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

MERKEL CELL CARCINOMA, RECURRENT

Get alerted when new MERKEL CELL CARCINOMA, RECURRENT trials appear

New drug trial offers hope for Tough-to-Treat neuroendocrine cancers